MNPR vs JNJ: Which Stock is Better?
Side-by-side comparison of Monopar Therapeutics Inc and Johnson & Johnson in 2026
MNPR
Monopar Therapeutics Inc
—
JNJ
Johnson & Johnson
$248.82
Key Metrics Comparison
| Metric | MNPR | JNJ | Winner |
|---|---|---|---|
| Market Cap | $431.35M | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze MNPR
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MNPR or JNJ a better investment?
Comparing MNPR and JNJ: Monopar Therapeutics Inc has a market cap of $431.35M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MNPR and JNJ?
MNPR (Monopar Therapeutics Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MNPR or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MNPR or JNJ?
Both MNPR and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: MNPR or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: MNPR or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $431.35M for MNPR.
Should I buy MNPR or JNJ in 2026?
Both MNPR and JNJ have investment merit. MNPR trades at $N/A while JNJ trades at $248.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MNPR and JNJ stock?
Key differences: Market Cap ($431.35M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy MNPR or JNJ in 2026?
The choice between MNPR and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between MNPR and JNJ?
MNPR (Monopar Therapeutics Inc) has a market cap of $431.35M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.